Table 2.
Single marker-based association analyses for the 6 SNPs included in the validation stage with respect to osteoporosis.
| CHR | SNP | POS | A1 | OR_1* | STAT_1* | P_1* | OR_2** | STAT_2** | P_2** |
|---|---|---|---|---|---|---|---|---|---|
| 1 | rs2772304 | 68636580 | A | 1.15 | 2.02 | 0.0434 | 1.11 | 1.80 | 0.0727 |
| 1 | rs12725769 | 68637158 | C | 0.98 | −0.29 | 0.7746 | 0.99 | −0.22 | 0.8250 |
| 1 | rs59393705 | 68644066 | C | 1.01 | 0.07 | 0.9422 | 0.99 | −0.23 | 0.8183 |
| 1 | rs2772297 | 68652084 | T | 1.04 | 0.54 | 0.5895 | 1.02 | 0.29 | 0.7754 |
| 1 | rs2026749 | 68653489 | G | 0.99 | −0.22 | 0.8234 | 0.99 | −0.13 | 0.8970 |
| 1 | rs2566752 | 68656697 | C | 0.78 | −4.12 | 3.73E-05 | 0.80 | −4.27 | 1.96E-05 |
*odds ratio, t-statistics, and p values for discovery stage.
**odds ratio, t-statistics, and p values for validation stage.